Hence, auto‐activating c‐Kit promotes the relapse of tumors derived from residual GIST‐430/654 cells in the xenograft model after the cessation of NN2101‐DM1 treatment. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.